InvestorsHub Logo
Followers 59
Posts 11484
Boards Moderated 0
Alias Born 07/16/2006

Re: DewDiligence post# 17987

Sunday, 12/03/2017 5:10:02 PM

Sunday, December 03, 2017 5:10:02 PM

Post# of 20689

The Orencia and Necuparanib disclosures didn't attain the threshold of materiality that would mandate a quick 8-K filing, so we can't really grade MNTA's disclosure policy based on those events.



If the above items effect the equity price wouldn't you think they should be reported? Wheeler sold 35K shares in early October, don't you think we should know if he knew Orencia flopped at that point.